Our

Partners

worldwide
OBESITY: 16.9% of adult population is overweight
more than 30% of the population is affected by weight problems*
OBESITY: 16.9% of adult population is overweight
more than 30% of the population is affected by weight problems*
6.5% of the population is affected by DIABETES*
7% of adult population is affected by GERD*
HEART DISEASES: 117 deaths per 100,000 people caused by ischemic heart disease,54 deaths per 100,000 people due to stroke*
HEART DISEASES: 117 deaths per 100,000 people caused by ischemic heart disease, 54 deaths per 100,000 people due to stroke*
PSORIASIS: from 2 to 3% of the population is subject to psoriasis*
DEPRESSION: the costs related to the depression syndrome
are on average 10% of total health care costs*
10% of adult population is affected by CONSTIPATION*
*OCSE
MedAutonomic contracted Stellartech Research Corporation
In April 2014, MedAutonomic contracted Stellartech Research Corporation www.stellartechresearch.com to develop the Brain NeuroModulator prototype.
Stellartech is based in Silicon Valley and is a leader in design, development, and contract manufacturing of sophisticated medical systems. Many systems Stellartech develops utilize radiofrequency, ultrasound, and other energy sources. The technology often incorporates complex electronics for delivery of therapeutic energy, and sensing of physiological signals in noisy environments. Stellartech partners with companies of all sizes to take product concepts through proof-of-principle, prototype, clinical evaluation, safety certification, regulatory approval, and manufacturing. Stellartech works to understand the scientific and clinical principles underlying the applications, as well as their particular regulatory environments.

MedAutonomic cooperates with Istituto Italiano di Tecnologia (IIT)
MedAutonomic and IIT (https://www.iit.it/institute/istituto-italiano-di-tecnologia) are working in a joint effort to design, prototype and produce state of the art components for the development of innovative medical devices that produce power through body energy harvesting.
The Institute’s scientific activity is composed of 11 research centers throughout Italy (Torino, Milano, Trento, Parma, Roma, Pisa, Napoli, Lecce, Ferrara) and abroad (MIT and Harvard University, USA) which, along with the Genoa-based Central Lab, implement the research programs included in the 2015-2017 Strategic Plan.

MedAutonomic’s cooperation with Milan University – Faculty of Medicine
In April 2016 MedAutonomic started cooperation with Milan University’s Clinical and Scientific Institute in San Donato Milanese, Surgical and Digestive Endoscopical Department headed by Professor Luigi Bonavina (www.unimi.it).  The focus of the cooperation is a structured trial program for the Brain NeuroModulator.
MedAutonomic Inc. - 1235 Traud Drive - Concord CA - 94518 USA - info@medautonomic.com
Powered by Newappeal s.r.l.